相关实验视频
Updated: May 14, 2026

07:55
The Influence of Liver Resection on Intrahepatic Tumor Growth
Published on: April 9, 2016
9.4K
胆道和血管切除类型对肝切除术中患病率的影响 血管参与肝切除术
Jonatha C F da Silva1, Alessandro L Diniz1, Silvio M Torres1
1Department of Abdominal Surgery, A. C. Camargo Cancer Center, São Paulo, Brazil.
Journal of surgical oncology
|August 6, 2024
概括
血管切除的肝切除术在专门中心的特定情况下是安全的. 相关的胆管切除和血管切除类型显著影响患者的发病率结果.
科学领域:
- 手术瘤学手术瘤学
- 肝胆道手术 肝胆道手术
- 血管重建 血管重建
背景情况:
- 涉及血管切除的肝切除术带来了重大的外科手术挑战.
- 这些复杂的手术由于长时间的手术时间和血管操纵而带来风险.
- 一项机构审查评估了这些手术的结果和影响因素.
研究的目的:
- 在接受肝切除术并进行血管切除的患者中评估死亡率和发病率.
- 确定影响结果的临床,实验室,病理和手术因素.
主要方法:
- 对一个潜在的数据库进行了队列分析.
- 术后生存率和发病率使用克拉维恩 - 丁多评分系统进行评估.
- 分析了巴西癌症中心10年来31例病例的数据.
主要成果:
- 大型肝切除术,输血和全身治疗并没有显著影响发病率或死亡率.
- 相关胆道切除和血管切除的类型是影响发病率的统计学上显著因素 (p=0.006).
结论:
- 血管切除的肝切除术可以在选择的患者中安全地在大量的转诊中心进行.
- 仔细考虑相关的胆管切除和血管切除类型对于患者选择和程序规划至关重要.
相关概念视频
Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

